These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29682347)

  • 1. Prevalence of Microalbuminuria in Adult Patients with Sickle Cell Disease in Eastern Saudi Arabia.
    Alkhunaizi AM; Al-Khatti AA; Alkhunaizi MA
    Int J Nephrol; 2018; 2018():5015764. PubMed ID: 29682347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinuria in children with sickle cell disease.
    Marsenic O; Couloures KG; Wiley JM
    Nephrol Dial Transplant; 2008 Feb; 23(2):715-20. PubMed ID: 18065783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal abnormalities in patients with sickle cell disease: a single center report from Saudi Arabia.
    Aleem A
    Saudi J Kidney Dis Transpl; 2008 Mar; 19(2):194-9. PubMed ID: 18310866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal outcomes in pediatric patients with sickle cell disease: a single center experience in Saudi Arabia.
    Monagel DA; Algahtani SS; Karawagh LA; Althubaity WD; Azab SA; Haneef DF; Elimam N
    Front Pediatr; 2023; 11():1295883. PubMed ID: 38161437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteinuria in patients with sickle cell disease.
    Alkhunaizi AM; Al-Khatti AA
    Saudi J Kidney Dis Transpl; 2014 Sep; 25(5):1038-41. PubMed ID: 25193903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prevalence of Cardiovascular Manifestations in Pediatric Sickle Cell Anemia Patients in a Large Tertiary Care Hospital in the Western Region of Saudi Arabia.
    Waggass R; Alhindi AK; Bagabas IS; Alsaegh MH; Alsharef NK; Morya RE; Khan MA; Jastaniah W
    Cureus; 2023 Mar; 15(3):e35751. PubMed ID: 37020484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and correlates of microalbuminuria in Yemeni children with sickle cell disease.
    Al-Musawa FE; Al-Saqladi AM
    Saudi J Kidney Dis Transpl; 2019; 30(4):832-842. PubMed ID: 31464240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiorenal risk prevalence in sickle cell hemoglobinopathy.
    Abo-Zenah H; Moharram M; El Nahas AM
    Nephron Clin Pract; 2009; 112(2):c98-c106. PubMed ID: 19390209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Predictive Factors for Leg Ulcers in Sickle Cell Disease Patients in Saudi Arabia: A Cross-Sectional Observational Study.
    Kaliyadan F; Alkhars AZ; Albaqshi AA; AlHajri HM; Albaqshi NK; Aldihnayn RM; Almarzooq ZY
    Cureus; 2020 Oct; 12(10):e11280. PubMed ID: 33274155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and associations of microalbuminuria in proteinuria-negative patients with type 2 diabetes in two regional hospitals in Cameroon: a cross-sectional study.
    Efundem NT; Assob JCN; Feteh VF; Choukem SP
    BMC Res Notes; 2017 Sep; 10(1):477. PubMed ID: 28899432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in urine albumin to creatinine ratio with the initiation of hydroxyurea therapy among children and adolescents with sickle cell disease.
    Tehseen S; Joiner CH; Lane PA; Yee ME
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28612449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria in adult Saudi patients with sickle cell disease is not associated with identifiable risk factors.
    Aleem A
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):903-8. PubMed ID: 20814129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease.
    Becton LJ; Kalpatthi RV; Rackoff E; Disco D; Orak JK; Jackson SM; Shatat IF
    Pediatr Nephrol; 2010 Aug; 25(8):1505-11. PubMed ID: 20505954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microalbuminuria: what is it? Why is it important? What should be done about it?
    Bakris GL
    J Clin Hypertens (Greenwich); 2001; 3(2):99-102. PubMed ID: 11416691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early blood transfusions protect against microalbuminuria in children with sickle cell disease.
    Alvarez O; Montane B; Lopez G; Wilkinson J; Miller T
    Pediatr Blood Cancer; 2006 Jul; 47(1):71-6. PubMed ID: 16261557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters.
    Al-Rubeaan K; Siddiqui K; Alghonaim M; Youssef AM; AlNaqeb D
    Ann Saudi Med; 2018; 38(1):46-56. PubMed ID: 29295969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
    Sasongko TH; Nagalla S; Ballas SK
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009191. PubMed ID: 23543572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
    Sasongko TH; Nagalla S; Ballas SK
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD009191. PubMed ID: 26041152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. End-stage renal disease in patients with sickle cell disease.
    Alkhunaizi AM; Al-Khatti AA; Al-Mueilo SH; Amir A; Yousif B
    Saudi J Kidney Dis Transpl; 2017; 28(4):751-757. PubMed ID: 28748876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Urine Microalbumin-to-Creatinine Ratio in Children with Sickle Cell Disease over Time.
    Shatat IF; Qanungo S; Hudson S; Laken MA; Hailpern SM
    Front Pediatr; 2016; 4():106. PubMed ID: 27774444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.